Loading clinical trials...
Loading clinical trials...
Cardiac amyloidosis (CA) has recently been reported as a common cause of heart failure with preserved left ventricular ejection fraction (HFpEF), with a prevalence of 6% in elderly HFpEF patients. How...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Tunis El Manar
NCT06762964 · Fontan Circulation, Single Ventricle Heart Disease, and more
NCT07083011 · Heart Failure With Preserved Ejection Fraction
NCT07037459 · Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, and more
NCT06427304 · Cardiac Amyloidosis
NCT06015776 · Diastolic Heart Failure, Heart Failure With Preserved Ejection Fraction
Security Hospital Forces
La Marsa, Tunis Governorate
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions